Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study

Figure 2

Predicted and observed HPV prevalence and cervical cancer incidence. Data on HPV prevalence in cytologically / histologically normal women (Figure 2A) obtained from analysis of Hybrid Capture II testing performed as part of the IARC/CICAMS study to obtain information on HPV positivity rates by 5-year age group [5]. The average incidence observed in unscreened populations of 24 less developed countries (Figure 2B) was calculated using data from IARC's Cancer Incidence in Five Continents Vol. VIII, which uses the Segi world standard population [14, 15].

Back to article page